欢迎您！东篱公司
退出
-
申报数据库
-
立项数据库
-
成果数据库
-
项目获奖数据库
中文摘要：
抗血管内皮生长因子疗法的应用是渗出型老年性黄斑变性治疗中的重大突破，但作为一种新兴疗法，其疗效持久性、药物副作用、药物选择等方面存在的问题也正逐步显现。充分认识该疗法的局限性以及应用过程中可能发生的副作用，加强临床监测，提倡个体化治疗，以提高其疗效和安全性是值得关注和重视的问题。
英文摘要：
The introduction of anti-vascular endothelial growth factor （VEGF） therapy represents a landmark in the management of wet age-related macular degeneration （AMD）. However, as a new therapy, several problems such as durability of the therapeutic effects, medication side effects, and medication selection have emerged. We should make appoint of improving the therapeutic effect and safety by realizing the limitation of the therapy, monitoring the clinical potential adverse reactions of anti-VEGF agents, and recommending individualized treatment.
同期刊论文项目
同项目期刊论文
Role of PI3K/Akt and MEK/ERK in Mediating Hypoxia-Induced Expression of HIF-1 alpha and VEGF in Lase
Choroidal neovascularization in age-related macular degeneration depends on vascular endothelial gro
Inhibitory Efficacy of Hypoxia-inducible factor 1α Short Hairpin RNA Plasmid DNA loaded Poly (D, L-l
Inhibition of proliferation, migration and tube formation of choroidal microvascular endothelial cel
Nicotine promotes contribution of bone marrow-derived cells to experimental choroidal neovasculariza
Alterations of activity and intracellular distribution of the 20S proteasome in ageing retinal pigme
期刊信息
位置：